Literature DB >> 8145706

1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention.

.   

Abstract

These guidelines for the treatment of patients with sexually transmitted diseases (STDs) were developed by staff members of CDC after consultation with a group of invited experts who met in Atlanta on January 19-21, 1993. Included are new recommendations for single-dose oral therapy for gonococcal infections, chlamydial infections, and chancroid; new regimens for the treatment of bacterial vaginosis (BV) and outpatient management of pelvic inflammatory disease (PID); a new patient-applied medication for treatment of genital warts; and a revised approach to the management of victims of sexual assault. This report includes new sections on subclinical human papillomavirus (HPV) infections and cervical cancer screening for women who attend STD clinics or who have a history of STDs. These recommendations also include expanded sections on the management of patients with asymptomatic human immunodeficiency virus (HIV) infection; vulvovaginal candidiasis (VVC); STDs among patients coinfected with HIV; and STDs among infants, children, and pregnant women.

Entities:  

Mesh:

Year:  1993        PMID: 8145706

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  27 in total

Review 1.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

2.  In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.

Authors:  Shuxian Shang; Longqing Xia; Mingying Zhong; Jinping Zhang; Jianbin Zhao; Xiangdong Gong; David Mabey; Qianqiu Wang
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Continuous surveillance of antibiotic resistant Neisseria gonorrhoeae: A tool to forewarn emerging trends in resistance.

Authors:  K H Yeung
Journal:  Can J Infect Dis       Date:  1995-11

4.  Cervicitis of unknown etiology.

Authors:  Stephanie N Taylor
Journal:  Curr Infect Dis Rep       Date:  2014-07       Impact factor: 3.725

5.  Incidence of three sexually transmitted diseases during a safer sex promotion program for HIV-infected women.

Authors:  P Kissinger; R Clark; J Dumestre; R Bessinger
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

6.  Comparison of Digene hybrid capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens.

Authors:  Ling H Darwin; Allison P Cullen; Patrick M Arthur; Carole D Long; Kim R Smith; Jennifer L Girdner; Edward W Hook; Thomas C Quinn; Attila T Lorincz
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Relative performance of three methods for diagnosing bacterial vaginosis during pregnancy.

Authors:  Vijaya K Hogan; Jennifer F Culhane; Jane Hitti; Virginia A Rauh; Kelly F McCollum; Kathy J Agnew
Journal:  Matern Child Health J       Date:  2007-09-15

8.  Disparities in the provision of sexually transmitted disease and pregnancy testing and prophylaxis for sexually assaulted women in Rhode Island emergency departments.

Authors:  Roland C Merchant; Benjamin Z Phillips; Allison K Delong; Kenneth H Mayer; Bruce M Becker
Journal:  J Womens Health (Larchmt)       Date:  2008-05       Impact factor: 2.681

Review 9.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

10.  Adequacy of testing, empiric treatment, and referral for adult male emergency department patients with possible chlamydia and/or gonorrhoea urethritis.

Authors:  R C Merchant; D M Depalo; M D Stein; J D Rich
Journal:  Int J STD AIDS       Date:  2009-08       Impact factor: 1.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.